Results 191 to 200 of about 47,328 (256)

TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC

open access: yesThoracic Cancer, Volume 17, Issue 16, August 2026.
TLS in lung cancer adjuvant therapy: (A) cellular composition (T/B cells, DCs); (B) mechanistic pathways (antigen presentation, GC‐like B responses, TRM maintenance); (C) clinical evaluation (IHC, digital pathology, spatial transcriptomics); (D) future directions (dynamic monitoring, intercellular interactions, multicenter trials, clinical translation).
Zhiqi Li   +6 more
wiley   +1 more source

APOBEC3A is the predominant global editor of cytosines in human mRNAs and in single-strand RNA viruses. [PDF]

open access: yesG3 (Bethesda)
Kockler ZW   +11 more
europepmc   +1 more source

Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy

open access: yesAging Cell, Volume 25, Issue 8, August 2026.
MSC rejuvenation strategies and functional outcomes. Aging‐associated alterations in MSCs, including increased IL‐6/IL‐8 secretion, ROS accumulation, epigenetic drift, and mitochondrial dysfunction, impair stemness. Rejuvenation approaches, epigenetic modulation (VPA, AZAc, OSKM, TERT), metabolic interventions (resveratrol, calcitriol, NMD, asprosin ...
Astrid Sodomaco   +8 more
wiley   +1 more source

The oncogenic control of nucleotide synthesis. [PDF]

open access: yesOncogenesis
Vidal-Cruchez O, Ben-Sahra I.
europepmc   +1 more source

Double-stranded DNA deaminase DddA<sup>E1347A</sup> can increase the efficiency and targeting range of cytidine base editors. [PDF]

open access: yesGenome Biol
Qian Y   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy